Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Trading Down 0% – Should You Sell?

Shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) dropped 0% during trading on Thursday . The company traded as low as $27.36 and last traded at $27.52. Approximately 7,475 shares changed hands during mid-day trading, a decline of 28% from the average daily volume of 10,417 shares. The stock had previously closed at $27.53.

Fidelity Disruptive Medicine ETF Trading Down 0.2%

The firm has a market cap of $63.18 million, a P/E ratio of 41.33 and a beta of 1.00. The firm’s 50 day moving average is $27.62 and its two-hundred day moving average is $25.73.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC lifted its position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 4.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 714,991 shares of the company’s stock after buying an additional 31,629 shares during the period. Wealth Enhancement Advisory Services LLC owned about 31.09% of Fidelity Disruptive Medicine ETF worth $19,712,000 as of its most recent SEC filing.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.